Fact CheckerSign in

NCT07510087Recruiting

Glaucoma Related Quality of Life

Source: ClinicalTrials.gov · Last updated 6 Apr 2026

Brief summary (registry, in English)

Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.

Status (registry)
Recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
30 Dec 2024
Start date
30 Dec 2024
Primary completion date
30 Nov 2026
Lead sponsor
Marc Toeteberg-Harms
Diseases
Glaucoma
NCT number
NCT07510087

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 30 Dec 2024 to the primary completion date, 30 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inclusion:
  • diagnosis of glaucoma (open- as well as closed-angle glaucoma, primary and secondary glaucomas)
  • 18 years of age or older with no upper limit
  • male and female subjects
    • Exclusion:
  • absence of a diagnosis of glaucoma
  • less than 18 years of age

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Iowa, Dept. of Ophthalmology & Visual Sciences
Coordinator of this site? Confirm its status
Iowa CityUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.